secwatch.observer — SEC 8-K summary
======================================

Issuer:     Carisma Therapeutics Inc. (CARM)
CIK:        0001485003
Form:       8-K
Filed at:   2024-10-30T23:59:59+00:00
Accession:  0001104659-24-112629
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Carisma Therapeutics announces director resignation and appointment of Sohanya Cheng
--------------------------------------------------------------------------------

- Michael Torok resigns from board effective Oct 31, 2024; cites other professional commitments, no disagreement.
- Sohanya Cheng elected director effective Oct 31, 2024 as Class I director until 2027 annual meeting.
- Cheng will serve on audit committee (Chair: Marella Thorell, Sanford Zweifach, Cheng).
- Compensation: $40K annual cash retainer, plus committee fees, and option for 38,700 shares at Oct 31 closing price, vesting monthly over 3 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1485003/000110465924112629/0001104659-24-112629-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1485003/000110465924112629/tm2426977d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-112629

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer